Efficacy and safety of an NRTI-sparing regimen in antiretroviral-naïve HIV-infected patients: once-daily maraviroc plus lopinavir/ritonavir

por Nozza, S, Galli, L, Di Pietro, M, Mazzotta, F, Canducci, F, Pogliaghi, M, Chiappetta, S, Galli, A, Rusconi, V, Salpietro, S, Tambussi, G, Lazzarin, A
Publicado 2010